Pamela Maffioli

8.1k total citations · 1 hit paper
188 papers, 6.4k citations indexed

About

Pamela Maffioli is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Pamela Maffioli has authored 188 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Endocrinology, Diabetes and Metabolism, 53 papers in Molecular Biology and 43 papers in Pharmacology. Recurrent topics in Pamela Maffioli's work include Diabetes Treatment and Management (44 papers), Metabolism, Diabetes, and Cancer (35 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers). Pamela Maffioli is often cited by papers focused on Diabetes Treatment and Management (44 papers), Metabolism, Diabetes, and Cancer (35 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers). Pamela Maffioli collaborates with scholars based in Italy, Iran and Australia. Pamela Maffioli's co-authors include Giuseppe Derosa, Angela D’Angelo, Amirhossein Sahebkar, Arrigo F.G. Cicero, Elena Fogari, Davide Romano, Ilaria Ferrari, Sibilla Salvadeo, Francesco Di Pierro and Aldo Bonaventura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pamela Maffioli

188 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

State of the art paper Sulfonylureas and their use in clinical practice

2015 376 citations Pamela Maffioli, Giuseppe Derosa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamela Maffioli Italy	42	2.4k	2.0k	1.1k	974	831	188	6.4k
Diana M. Shih United States	49	912 0.4×	3.2k 1.6×	1.4k 1.3×	1.2k 1.3×	1.5k 1.8×	80	9.6k
Luis E. Simental‐Mendía Mexico	40	2.1k 0.9×	1.1k 0.6×	500 0.5×	1.1k 1.2×	992 1.2×	160	6.6k
Jordi Camps Spain	46	794 0.3×	1.4k 0.7×	804 0.7×	1.2k 1.3×	628 0.8×	252	7.1k
Giuseppe Derosa Italy	54	4.2k 1.8×	3.1k 1.5×	1.7k 1.6×	1.8k 1.8×	1.3k 1.6×	337	10.5k
Jorge Joven Spain	62	1.5k 0.6×	3.9k 2.0×	971 0.9×	1.9k 1.9×	1.1k 1.3×	377	12.2k
Hamid Nasri Iran	38	1.2k 0.5×	1.0k 0.5×	465 0.4×	654 0.7×	434 0.5×	350	6.1k
Jean‐Louis Chiasson Canada	36	4.6k 1.9×	1.7k 0.9×	713 0.7×	1.2k 1.3×	1.6k 1.9×	84	6.9k
Angela Pirillo Italy	36	1.4k 0.6×	1.4k 0.7×	364 0.3×	2.2k 2.3×	444 0.5×	116	6.0k
Tae‐Sook Jeong South Korea	45	997 0.4×	3.0k 1.5×	790 0.7×	732 0.8×	467 0.6×	191	6.6k
Joseph L. Evans United States	26	1.4k 0.6×	2.1k 1.0×	396 0.4×	712 0.7×	1.8k 2.2×	46	5.9k

Countries citing papers authored by Pamela Maffioli

Since Specialization

Citations

This map shows the geographic impact of Pamela Maffioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Maffioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Maffioli more than expected).

Fields of papers citing papers by Pamela Maffioli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Maffioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Maffioli. The network helps show where Pamela Maffioli may publish in the future.

Co-authorship network of co-authors of Pamela Maffioli

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Maffioli. A scholar is included among the top collaborators of Pamela Maffioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Maffioli. Pamela Maffioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Derosa, Giuseppe, Angela D’Angelo, Pamela Maffioli, Laura Cucinella, & Rossella E. Nappi. (2024). The Use of Nigella sativa in Cardiometabolic Diseases. Biomedicines. 12(2). 405–405. 5 indexed citations

Derosa, Giuseppe, Angela D’Angelo, Francesco Angelini, et al.. (2024). Nutraceuticals and Supplements in Management of Prediabetes and Diabetes. Nutrients. 17(1). 14–14. 6 indexed citations

Pierro, Francesco Di, Amjad Khan, Somia Iqtadar, et al.. (2023). Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial. Frontiers in Pharmacology. 13. 1096853–1096853. 39 indexed citations

Pierro, Francesco Di, Giuseppe Derosa, Pamela Maffioli, et al.. (2021). Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. International Journal of General Medicine. Volume 14. 2359–2366. 132 indexed citations

Pierro, Francesco Di, Somia Iqtadar, Amjad Khan, et al.. (2021). Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. International Journal of General Medicine. Volume 14. 2807–2816. 132 indexed citations

Derosa, Giuseppe, Angela D’Angelo, Paola Preti, & Pamela Maffioli. (2020). Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention. SHILAP Revista de lepidopterología. 1 indexed citations

Derosa, Giuseppe, et al.. (2020). An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia. SHILAP Revista de lepidopterología. 1 indexed citations

Pierro, Francesco Di, Aadil Khan, Alexander Bertuccioli, et al.. (2020). Quercetin Phytosome R as a potential candidate for managing COVID-19. 10. 5–5. 10 indexed citations

Derosa, Giuseppe, et al.. (2020). <p>An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 653–661. 18 indexed citations

10.

Derosa, Giuseppe, et al.. (2020). Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trial. International Journal for Vitamin and Nutrition Research. 92(2). 91–100. 5 indexed citations

11.

Derosa, Giuseppe & Pamela Maffioli. (2019). The cardiometabolic risk: a new concept for old diseases. 5 indexed citations

12.

Derosa, Giuseppe, Pamela Maffioli, Laura Scelsi, et al.. (2018). Canrenone on cardiovascular mortality in congestive heart failure. Pharmacological Research. 141. 46–52. 6 indexed citations

13.

Derosa, Giuseppe, Angela D’Angelo, Davide Romano, & Pamela Maffioli. (2017). Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes. Drug Design Development and Therapy. Volume 11. 1481–1488. 37 indexed citations

14.

Cicero, Arrigo F.G., Giuseppe Derosa, Pamela Maffioli, et al.. (2013). Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals. Current Topics in Nutraceutical Research. 11. 41–45. 3 indexed citations

15.

Derosa, Giuseppe, Arrigo F.G. Cicero, Ivano Franzetti, et al.. (2013). A Randomized, Double-Blind, Comparative Therapy Evaluating Sitagliptin Versus Glibenclamide in Type 2 Diabetes Patients Already Treated with Pioglitazone and Metformin: A 3-Year Study. Diabetes Technology & Therapeutics. 15(3). 214–222. 16 indexed citations

16.

Maffioli, Pamela, Elena Fogari, Angela D’Angelo, Tiziano Perrone, & Giuseppe Derosa. (2013). Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin. European Journal of Gastroenterology & Hepatology. 25(9). 1113–1122. 15 indexed citations

17.

Derosa, Giuseppe, Anna Carbone, Angela D’Angelo, et al.. (2013). Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin. Internal Medicine. 52(19). 2179–2187. 29 indexed citations

18.

Derosa, Giuseppe, Fabrizio Querci, Anna Carbone, et al.. (2012). Exenatide plus metformin compared with metformin alone on β‐cell function in patients with Type 2 diabetes. Diabetic Medicine. 29(12). 1515–1523. 58 indexed citations

19.

Derosa, Giuseppe & Pamela Maffioli. (2012). Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience. Diabetes Technology & Therapeutics. 14(4). 350–364. 47 indexed citations

20.

Derosa, Giuseppe & Pamela Maffioli. (2011). Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes. Diabetes Metabolic Syndrome and Obesity. 4. 263–263. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact